Drug intelligence / Profile preview

stramonium

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Inhalation, Topical, Smoked
01

Overview

Stramonium is a homeopathic drug prepared from the fresh plant Datura stramonium (Jimson weed), which belongs to the Solanaceae family[4][6][7]. In homeopathy, it is primarily used to manage symptoms of extreme mental and emotional disturbances, including intense fear, vivid hallucinations, convulsions, and various neurological disorders. Its key clinical indications include schizophrenia, mania, delirium, stammering, chorea, epilepsy, meningitis, headaches, and strabismus[1][2][4][8]. The core bioactive components are tropane alkaloids—atropine, hyoscyamine, and scopolamine—which antagonize muscarinic acetylcholine receptors (especially M2)[3][5][7]. These actions underpin its historical uses as a bronchodilator (antiasthmatic activity), anticholinergic agent, analgesic, and hallucinogen[3][7][12]. In non-homeopathic medical practice, stramonium has had limited and unsafe use for asthma, cough, and pain but carries significant risk of toxicity and is no longer recommended[5][7].

Brand names
Jimson weedThorn appleDevil’s snare
Other names
Datura stramoniumJimson weedThorn appleDevil’s snare
02

Targets

CHRM3 (M3)CHRM2 (M2)M1 (Muscarinic acetylcholine receptor M1)

Beyond the preview

Go deeper on stramonium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on stramonium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call